Rapid Risk Assessment: COVID-19 outbreaks in long-term care facilities in the EU/EEA in the context of current vaccination coverage
Coronavirus disease (COVID-19) outbreaks in long-term care facilities (LTCFs) in European Union and European Economic Area (EU/EEA) countries have caused significant morbidity and mortality since the beginning of the COVID-19 pandemic.
ECDC Rapid Risk Assessment: Several recent COVID-19 outbreaks in long-term care facilities in the EU/EEA
On 26 July ECDC published the Rapid Risk Assessment COVID-19 outbreaks in long-term care facilities in the EU/EEA in the context of current vaccine coverage, following several outbreaks that occurred in these settings during the past six months in several EU/EEA countries, resulting in some cases of severe disease and deaths.
COVID-19 in children and the role of school settings in transmission - second update
The aim of this document is to provide an update on the knowledge surrounding the role of children in the transmission of SARS-CoV-2 and the role of schools in the COVID-19 pandemic, focusing in particular on the experience in EU/EEA countries since the beginning of the pandemic. This document also addresses transmission to and from staff in school settings, school-related mitigation measures including risk communication, testing, contact tracing, and the effectiveness and impacts of school closures.
WHO and ECDC launch indicator framework to evaluate the public health effectiveness of digital proximity tracing solutions
The European Centre for Disease Prevention and Control (ECDC) together with the World Health Organization (WHO) through its Headquarters and Regional Office for Europe (WHO/Europe) have developed the first indicator framework to evaluate the public health effectiveness of digital proximity tracing solutions.
Indicator framework to evaluate the public health effectiveness of digital proximity tracing solutions
This indicator framework, developed by ECDC together with WHO/Europe, is intended for use by relevant national health authorities, public health and related institutions and their partners involved in the planning, implementation, monitoring and evaluation of contact tracing activities.
Overview of EU/EEA country recommendations on COVID-19 vaccination with Vaxzevria, and a scoping review of evidence to guide decision-making
This technical report provides a summary of the evidence available at the time of the publication and what will be required in the future to support EU/EEA countries taking decisions on administration of the second dose, following a first dose of Vaxzevria. Since new evidence is being generated continuously and safety monitored on an ongoing basis, it is essential for readers to consider the latest available information.
Considerations on the use of rapid antigen detection (including self-) tests for SARS-CoV-2 in occupational settings
This document outlines the public health considerations for the use of rapid antigen detection tests (RADTs), including self-test RADTs to detect SARS-CoV-2 in individuals in occupational settings in the European Union/European Economic Area (EU/EEA), and provides information on the use of such tests in an occupational safety and health at work context.
Stop the spread! Could diagnostic antigen tests help control COVID-19 transmission in workplaces?
ECDC has joined forces with EU-OSHA, the EU agency for occupational safety and health, to explore the use of rapid antigen tests for SARS-CoV-2, the virus that causes COVID-19, in the workplace.